Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Sanofi (SNYNF) Goodwill (2016 - 2025)

Historic Goodwill for Sanofi (SNYNF) over the last 17 years, with Q4 2025 value amounting to $48.1 billion.

  • Sanofi's Goodwill rose 370.89% to $48.1 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $48.1 billion, marking a year-over-year increase of 370.89%. This contributed to the annual value of $46.7 billion for FY2025, which is 60.26% down from last year.
  • Sanofi's Goodwill amounted to $48.1 billion in Q4 2025, which was up 370.89% from $45.6 billion recorded in Q2 2025.
  • Sanofi's 5-year Goodwill high stood at $55.0 billion for Q4 2021, and its period low was $45.6 billion during Q2 2025.
  • Moreover, its 5-year median value for Goodwill was $53.4 billion (2023), whereas its average is $51.5 billion.
  • Per our database at Business Quant, Sanofi's Goodwill skyrocketed by 866.97% in 2021 and then tumbled by 1544.91% in 2025.
  • Sanofi's Goodwill (Quarter) stood at $55.0 billion in 2021, then fell by 7.41% to $50.9 billion in 2022, then grew by 4.43% to $53.2 billion in 2023, then dropped by 12.78% to $46.4 billion in 2024, then grew by 3.71% to $48.1 billion in 2025.
  • Its Goodwill stands at $48.1 billion for Q4 2025, versus $45.6 billion for Q2 2025 and $46.4 billion for Q4 2024.